New Strong Sell Stocks for January 21st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Ceragon Networks CRNT is a leading provider of high-capacity wireless backhaul solutions for cellular and fixed wireless operators, enterprises and government organizations. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 60 days.

Kura Oncology KURA is a biopharmaceutical company which is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. The Zacks Consensus Estimate for its current year earnings has been revised almost 13.6% downward over the last 60 days.

Clearside Biomedical CLSDQ is a biopharmaceutical company which is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space (TM) microinjector. The Zacks Consensus Estimate for its current year earnings has been revised almost 12.5% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Source Zacks-com